Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Ernst

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Canadian Respiratory Journal|July 9, 2005
Patterns and determinants of compliance with inhaled steroids in adults with asthmaYves Lacasse, Hélène Archibald, Pierre Ernst, et al.
American Journal of Respiratory and Critical Care Medicine|April 3, 2007
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumoniaPierre Ernst, Anne V Gonzalez, Paul Brassard, et al.
The European Respiratory Journal|November 21, 2019
Inhaled corticosteroid use and the incidence of lung cancer in COPDSamy Suissa, Sophie Dell'Aniello, Anne V Gonzalez, et al.
Canadian Respiratory Journal|March 11, 2004
A population-based evaluation of a regional asthma education centreSimone Cowan, Pierre Ernst, André Cartier, et al.
Chest|July 19, 2017
Long-term Use of Inhaled Corticosteroids in COPD and the Risk of FractureAnne V Gonzalez, Janie Coulombe, Pierre Ernst, et al.
British Journal of Clinical Pharmacology|April 21, 2017
Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort studyChristina J Qian, Janie Coulombe, Samy Suissa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
Phenotypic heterogeneity of potentially curable non-small-cell lung cancer: cohort study with cluster analysisLama Sakr, David Small, Goulnar Kasymjanova, et al.
The American Journal of Medicine|July 6, 2004
Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritisSamy Suissa, Pierre Ernst, Marie Hudson, et al.
COPD|August 27, 2025
Letter Reply to: Reassessing Gabapentinoids in Chronic Obstructive Pulmonary Disease: Emerging Respiratory Safety ConcernsOmotayo Olaoye, Sophie Dell'Aniello, Pierre Ernst, et al.
COPD|July 23, 2025
Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort StudyOmotayo Olaoye, Sophie Dell'Aniello, Pierre Ernst, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Canadian Respiratory Journal|July 9, 2005
Patterns and determinants of compliance with inhaled steroids in adults with asthmaYves Lacasse, Hélène Archibald, Pierre Ernst, et al.
American Journal of Respiratory and Critical Care Medicine|April 3, 2007
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumoniaPierre Ernst, Anne V Gonzalez, Paul Brassard, et al.
The European Respiratory Journal|November 21, 2019
Inhaled corticosteroid use and the incidence of lung cancer in COPDSamy Suissa, Sophie Dell'Aniello, Anne V Gonzalez, et al.
Canadian Respiratory Journal|March 11, 2004
A population-based evaluation of a regional asthma education centreSimone Cowan, Pierre Ernst, André Cartier, et al.
Chest|July 19, 2017
Long-term Use of Inhaled Corticosteroids in COPD and the Risk of FractureAnne V Gonzalez, Janie Coulombe, Pierre Ernst, et al.
British Journal of Clinical Pharmacology|April 21, 2017
Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort studyChristina J Qian, Janie Coulombe, Samy Suissa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
Phenotypic heterogeneity of potentially curable non-small-cell lung cancer: cohort study with cluster analysisLama Sakr, David Small, Goulnar Kasymjanova, et al.
The American Journal of Medicine|July 6, 2004
Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritisSamy Suissa, Pierre Ernst, Marie Hudson, et al.
COPD|August 27, 2025
Letter Reply to: Reassessing Gabapentinoids in Chronic Obstructive Pulmonary Disease: Emerging Respiratory Safety ConcernsOmotayo Olaoye, Sophie Dell'Aniello, Pierre Ernst, et al.
COPD|July 23, 2025
Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort StudyOmotayo Olaoye, Sophie Dell'Aniello, Pierre Ernst, et al.
Pageof 18